| Year |
Citation |
Score |
| 2018 |
Miller ML, Lohmueller J, McKolanis JR, Schoen R, Finn OJ. Abstract 5643: TCRβ repertoire analysis from a prophylactic MUC1 cancer vaccine trial Cancer Research. 78: 5643-5643. DOI: 10.1158/1538-7445.Am2018-5643 |
0.321 |
|
| 2017 |
Lohmueller JJ, Ham JD, Kvorjak M, Finn OJ. mSA2 affinity-enhanced biotin-binding CAR T cells for universal tumor targeting. Oncoimmunology. 7: e1368604. PMID 29296519 DOI: 10.1080/2162402X.2017.1368604 |
0.349 |
|
| 2017 |
Lohmueller J, Finn OJ. Current modalities in cancer immunotherapy: Immunomodulatory antibodies, CARs and vaccines. Pharmacology & Therapeutics. PMID 28322974 DOI: 10.1016/J.Pharmthera.2017.03.008 |
0.302 |
|
| 2017 |
Lohmueller JJ, Ham JD, Finn OJ. Abstract 3747: msa2 biotin-binding CAR combined with biotinylated tumor-specific antibodies or DNA aptamers for universal cancer immunotherapy Immunology. 77: 3747-3747. DOI: 10.1158/1538-7445.Am2017-3747 |
0.319 |
|
| 2016 |
Lohmueller JJ, Sato S, Popova L, Chu IM, Tucker MA, Barberena R, Innocenti GM, Cudic M, Ham JD, Cheung WC, Polakiewicz RD, Finn OJ. Antibodies elicited by the first non-viral prophylactic cancer vaccine show tumor-specificity and immunotherapeutic potential. Scientific Reports. 6: 31740. PMID 27545199 DOI: 10.1038/Srep31740 |
0.346 |
|
| 2015 |
Lohmueller JJ, Sato S, Cheung WC, Chu I, Popova L, Manning CA, Crosby K, Grange C, Ham JD, Polakiewicz RD, Finn OJ. Abstract 2509: Human anti-MUC1 antibodies elicited by a prophylactic cancer vaccine for mAb and CAR-modified T cell immunotherapies Immunology. 75: 2509-2509. DOI: 10.1158/1538-7445.Am2015-2509 |
0.309 |
|
| 2014 |
Lienert F, Lohmueller JJ, Garg A, Silver PA. Synthetic biology in mammalian cells: next generation research tools and therapeutics. Nature Reviews. Molecular Cell Biology. 15: 95-107. PMID 24434884 DOI: 10.1038/Nrm3738 |
0.516 |
|
| 2013 |
Selgrade DF, Lohmueller JJ, Lienert F, Silver PA. Protein scaffold-activated protein trans-splicing in mammalian cells. Journal of the American Chemical Society. 135: 7713-9. PMID 23621664 DOI: 10.1021/Ja401689B |
0.45 |
|
| 2012 |
Garg A, Lohmueller JJ, Silver PA, Armel TZ. Engineering synthetic TAL effectors with orthogonal target sites. Nucleic Acids Research. 40: 7584-95. PMID 22581776 DOI: 10.1093/Nar/Gks404 |
0.508 |
|
| 2012 |
Lohmueller JJ, Armel TZ, Silver PA. A tunable zinc finger-based framework for Boolean logic computation in mammalian cells. Nucleic Acids Research. 40: 5180-7. PMID 22323524 DOI: 10.1093/Nar/Gks142 |
0.51 |
|
| 2012 |
Leisner M, Bleris L, Lohmueller J, Xie Z, Benenson Y. MicroRNA circuits for transcriptional logic. Methods in Molecular Biology (Clifton, N.J.). 813: 169-86. PMID 22083742 DOI: 10.1007/978-1-61779-412-4_10 |
0.357 |
|
| 2010 |
Leisner M, Bleris L, Lohmueller J, Xie Z, Benenson Y. Rationally designed logic integration of regulatory signals in mammalian cells. Nature Nanotechnology. 5: 666-70. PMID 20622866 DOI: 10.1038/Nnano.2010.135 |
0.357 |
|
| 2007 |
Lohmueller J, Neretti N, Hickey B, Kaka A, Gao A, Lemon J, Lattanzi V, Goldstein P, Tam LK, Schmidt M, Brodsky AS, Haberstroh K, Morgan J, Palmore T, Wessel G, et al. Progress toward construction and modelling of a tri-stable toggle switch in E. coli Iet Synthetic Biology. 1: 25-28. DOI: 10.1049/Iet-Stb:20070001 |
0.3 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2015 |
Lohmueller JJ. Mammalian synthetic gene circuits Proceedings of the Acm Great Lakes Symposium On Vlsi, Glsvlsi. 20: 325-326. DOI: 10.1145/2742060.2743764 |
0.299 |
|
| 2017 |
Cascio S, Faylo JL, Sciurba JC, Xue J, Ranganathan S, Lohmueller JJ, Beatty PL, Finn OJ. Abnormally glycosylated MUC1 establishes a positive feedback circuit of inflammatory cytokines, mediated by NF-κB p65 and EzH2, in colitis-associated cancer. Oncotarget. 8: 105284-105298. PMID 29285251 DOI: 10.18632/Oncotarget.22168 |
0.288 |
|
| 2006 |
Sabeti PC, Schaffner SF, Fry B, Lohmueller J, Varilly P, Shamovsky O, Palma A, Mikkelsen TS, Altshuler D, Lander ES. Positive natural selection in the human lineage. Science (New York, N.Y.). 312: 1614-20. PMID 16778047 DOI: 10.1126/Science.1124309 |
0.283 |
|
| 2013 |
Kamberov YG, Wang S, Tan J, Gerbault P, Wark A, Tan L, Yang Y, Li S, Tang K, Chen H, Powell A, Itan Y, Fuller D, Lohmueller J, Mao J, et al. Modeling recent human evolution in mice by expression of a selected EDAR variant. Cell. 152: 691-702. PMID 23415220 DOI: 10.1016/J.Cell.2013.01.016 |
0.279 |
|
| 2007 |
Sabeti PC, Varilly P, Fry B, Lohmueller J, Hostetter E, Cotsapas C, Xie X, Byrne EH, McCarroll SA, Gaudet R, Schaffner SF, Lander ES, Frazer KA, Ballinger DG, et al. Genome-wide detection and characterization of positive selection in human populations. Nature. 449: 913-8. PMID 17943131 DOI: 10.1038/Nature06250 |
0.269 |
|
| 2023 |
Kvorjak M, Ruffo E, Tivon Y, So V, Parikh AB, Deiters A, Lohmueller J. Conditional control of universal CAR T cells by cleavable OFF-switch adaptors. Biorxiv : the Preprint Server For Biology. PMID 37292935 DOI: 10.1101/2023.05.22.541664 |
0.262 |
|
| 2023 |
Kvorjak M, Ruffo E, Tivon Y, So V, Parikh A, Deiters A, Lohmueller J. Conditional Control of Universal CAR T Cells by Cleavable OFF-Switch Adaptors. Acs Synthetic Biology. 12: 2996-3007. PMID 37791909 DOI: 10.1021/acssynbio.3c00320 |
0.262 |
|
| 2017 |
Lohmueller JJ, Ham JD, Kvorjak M, Finn OJ. mSA2 affinity-enhanced biotin-binding CAR T cells for universal tumor targeting. Oncoimmunology. 7: e1368604. PMID 29296519 DOI: 10.1080/2162402X.2017.1368604 |
0.259 |
|
| 2007 |
Lohmueller J, Hickey B, Kaka A, Gao A, Lemon J, Lattanzi V, Goldstein P, Tam L, Schmidt M, Cumbers J, Gagnon J, Urabe H, Jaklenec A, Wessel G. Progress toward the construction of a tri-stable genetic toggle switch in E. coli Bmc Systems Biology. 1. DOI: 10.1186/1752-0509-1-S1-P39 |
0.223 |
|
| 2021 |
Kataoka S, Manandhar P, Lee J, Workman CJ, Banerjee H, Szymczak-Workman AL, Kvorjak M, Lohmueller J, Kane LP. The costimulatory activity of Tim-3 requires Akt and MAPK signaling and its recruitment to the immune synapse. Science Signaling. 14. PMID 34131021 DOI: 10.1126/scisignal.aba0717 |
0.212 |
|
| 2023 |
Lontos K, Wang Y, Joshi SK, Frisch AT, Watson MJ, Kumar A, Menk AV, Wang Y, Cumberland R, Lohmueller J, Carrizosa E, Boyerinas B, Delgoffe GM. Metabolic reprogramming via an engineered PGC-1α improves human chimeric antigen receptor T-cell therapy against solid tumors. Journal For Immunotherapy of Cancer. 11. PMID 36914208 DOI: 10.1136/jitc-2022-006522 |
0.207 |
|
| 2023 |
Ruffo E, Butchy AA, Tivon Y, So V, Kvorjak M, Parikh A, Adams EL, Miskov-Zivanov N, Finn OJ, Deiters A, Lohmueller J. Post-translational covalent assembly of CAR and synNotch receptors for programmable antigen targeting. Nature Communications. 14: 2463. PMID 37160880 DOI: 10.1038/s41467-023-37863-5 |
0.205 |
|
| 2017 |
Cascio S, Faylo JL, Sciurba JC, Xue J, Ranganathan S, Lohmueller JJ, Beatty PL, Finn OJ. Abnormally glycosylated MUC1 establishes a positive feedback circuit of inflammatory cytokines, mediated by NF-κB p65 and EzH2, in colitis-associated cancer. Oncotarget. 8: 105284-105298. PMID 29285251 DOI: 10.18632/oncotarget.22168 |
0.186 |
|
| 2022 |
Lontos K, Wang Y, Colbert M, Kumar A, Joshi S, Philbin M, Wang Y, Frisch A, Lohmueller J, Rivadeneira DB, Delgoffe GM. Fully murine CD105-targeted CAR-T cells provide an immunocompetent model for CAR-T cell biology. Oncoimmunology. 11: 2131229. PMID 36275862 DOI: 10.1080/2162402X.2022.2131229 |
0.182 |
|
| 2024 |
Cho Y, Laird M, Bishop T, Li R, Ruffo E, Lohmueller J, Zervantonakis IK. CAR T cell infiltration and cytotoxic killing within the core of 3D breast cancer spheroids under control of antigen sensing in microwell arrays. Biorxiv : the Preprint Server For Biology. PMID 38654820 DOI: 10.1101/2024.03.14.585033 |
0.12 |
|
| 2019 |
Lohmueller J, Cascio S. Editorial. Cellular Immunology. 343: 103967. PMID 31447052 DOI: 10.1016/j.cellimm.2019.103967 |
0.014 |
|
| Hide low-probability matches. |